Welcome to the Newron Pharmaceuticals website.
We are a clinical-stage biopharmaceutical company.
Our shares are listed on the SIX Swiss Exchange (NWRN).
Our mission is to discover, develop and commercialise novel drugs to treat
diseases of the Central Nervous System (CNS) and pain.
February 10-11, 2014 - The Waldorf Astoria, New York City, US
January 13-16, 2014 - Westin St. Francis, San Francisco, CA, US
September 30 - October 1, 2013 - Hilton Zürich Airport, Zürich, Switzerland